SCHEMBL6400554

SCHEMBL6400554

NC(=O)N1C(=O)NC(c2ccc(Cl)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
MEN1 O00255 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
SLC9A1 P19634 1/20 0.38
LMNA P02545 2/20 0.37
ALOX12 P18054 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HTT P42858 3/20 0.37
POLB P06746 2/20 0.37
HSD17B10 Q99714 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GAA P10253 3/20 0.36
MAPT P10636 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
MC4R P32245 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6398623 0.85 ESR1 (0.40) KMT2AMEN1LMNAALDH1A1HSD17B10
SCHEMBL6404442 0.84 TDP1 (0.44) SLC9A1LMNAGAAMAPTSLC6A2
SCHEMBL6401309 0.83 LMNA (0.50) KMT2AMEN1LMNAALDH1A1SMN1; SMN2
SCHEMBL6399674 0.83 LMNA (0.50) KMT2AMEN1LMNAALDH1A1SMN1; SMN2
SCHEMBL6401145 0.80 ALDH1A1 (0.47) MAOAMAOBALDH1A1GAACYP3A4
SCHEMBL6404733 0.80 ALDH1A1 (0.47) MAOAMAOBALDH1A1GAACYP3A4
SCHEMBL6400557 0.76 ALDH1A1 (0.41) KMT2AMEN1LMNAALOX12ALDH1A1
SCHEMBL7076594 0.67 LMNA (0.54) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL10541831 0.67 SLC6A3 (0.50) KMT2AMEN1ALOX12ALDH1A1HTT
SCHEMBL6137194 0.66 MEN1 (0.42) KMT2AMEN1LMNAALOX12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 KMT2A 673/4885MEN1 1510/4885MAOA 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.